RadNet PE ratio RDNT

Share price divided by earnings per share over the last twelve months, since 2012.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 475×; Nov 2024
10-year median: 49.8×
10-year range: 16.8× to 495×
Peer median: 36.7×

RadNet has no meaningful PE ratio today: it lost $0.27 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Nov 2024, at 475×.

On the days it had one over the last ten years, its median was 49.8×, from 16.8× in May 2019 to 495× in Sep 2024.

PE ratio over time

median 49.8×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2024	475×	184×	495×
2023	169×	137×	181×
2022	157×	36.7×	169×
2021	46.3×	41.3×	182×
2020	443×	22.1×	447×
2019	29.7×	16.8×	29.7×
2018	54.1×	42.6×	54.1×
2017	43.9×	35.3×	63.0×
2016	64.5×	20.7×	68.0×
2015	24.7×	23.5×	44.9×
2014	n/m a value too high to mean anything
2013	8.7×	8.2×	9.7×
2012	7.8×	7.5×	15.1×

Against its peers

Companies in Medical - Diagnostics & Research nearest RadNet's size, closest first, today.

Company	PE ratio
RDNTRadNet	n/m
BLLNBillionToOne	166×
LNTHLantheus	24.2×
VCYTVeracyte	34.2×
CDNACareDx	33.4×
CAICaris Life Sciences	86.5×
BIOBio-Rad Laboratories	44.8×
RVTYRevvity	75.6×
MEDPMedpace	39.2×
LHLabcorp	27.2×
DGXQuest Diagnostics	25.7×
Peer median	36.7×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on RadNet

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.